Dr Omar Din

Omar Din is a specialist Consultant Clinical Oncologist who treats Prostate, Bladder, Kidney and Breast Cancers.  His training was at Weston Park Cancer Centre in Sheffield and Christie Hospital in Manchester. Following this, he completed a research MD degree at Sheffield and Leeds Cancer Centres. During this, he led a research project investigating the effect of adjuvant breast cancer therapy on the musculoskeletal system. An advocate of providing the most up to date treatments for his patients, he has been actively involved in clinical trials and research. He is also the local principal investigator on several national clinical trials.  He is actively involved in the training and educational supervision of Junior Doctors and Advanced Clinical Practitioners Research Publications (selected) Breast Cancer: Current opinion of aromatase inhibitor-induced arthralgia in breast cancer in the UK. Renal Cancer: Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer  Prostate Cancer: Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer Lung Cancer: Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres. Palliative: Palliative prostate radiotherapy for symptomatic advanced prostate cancer. www.researchgate.net Professional Memberships • British Medical Association  • Fellow of Royal College of Radiologists (FRCR)  • British Uro-Oncology Group • UK Breast Cancer Group • North of England Breast Cancer Symposium Current NHS/University Post • Consultant and Honorary Senior Clinical Lecturer in Clinical Oncology in Urological Malignancies and SABR at Weston Park Cancer Centre, Sheffield

Prostate Cancer Bladder and Urothelial Cancer Kidney Cancer SABR (Stereotactic Ablative Radiotherapy) Molecular Radiotherapy / Nuclear Medicine Therapy in Prostate Cancer Clinical Trials